Literature DB >> 8744585

env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization.

M A Penny1, S J Thomas, N W Douglas, S Ranjbar, H Holmes, R S Daniels.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8744585     DOI: 10.1089/aid.1996.12.741

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  5 in total

1.  The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity.

Authors:  R B Oelrichs; I L Shrestha; D A Anderson; N J Deacon
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi.

Authors:  Grace P McCormack; Judith R Glynn; Amelia C Crampin; Felix Sibande; Dominic Mulawa; Lyn Bliss; Philip Broadbent; Katia Abarca; Jorg M Pönnighaus; Paul E M Fine; Jonathan P Clewley
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  An unrelated monoclonal antibody neutralizes human immunodeficiency virus type 1 by binding to an artificial epitope engineered in a functionally neutral region of the viral envelope glycoproteins.

Authors:  Xinping Ren; Joseph Sodroski; Xinzhen Yang
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease.

Authors:  F Kirchhoff; P J Easterbrook; N Douglas; M Troop; T C Greenough; J Weber; S Carl; J L Sullivan; R S Daniels
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Functional chimeras of human immunodeficiency virus type 1 Gp120 and influenza A virus (H3) hemagglutinin.

Authors:  K M Copeland; A J Elliot; R S Daniels
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.